HIV News and Research

RSS

Research on twins indicates strong genetic influences in COVID-19

A new study discusses the strong possibility of multifactorial causation for SARS-CoV-2 infection using data from twin studies.

6 Oct 2021

Needle exchanges are targeted by eco-rooted lawsuits. A new California law will stop that.

For more than 30 years, public health officials and nonprofits in California have provided clean hypodermic needles to people who use them to inject drugs.

6 Oct 2021

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Researchers in the United States have shown that a compound currently used to treat cystinosis exhibits broad antiviral activity against variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

5 Oct 2021

Binghamton professor collaborates on $3.1 million grant to help Black and Latinx youth living with HIV

A new $3.1-million, four-year grant co-led by faculty at Binghamton University, State University of New York could help African American and Latinx youth living with HIV.

5 Oct 2021

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

A new study reports on the results of phase III clinical trial on the safety and efficacy of the AstraZeneca-Oxford COVID-19 vaccine.

5 Oct 2021

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Researchers from the University of Singapore have reviewed the data in post-vaccinated immunocompromised patients to examine the effectiveness of these vaccines in these patients.

5 Oct 2021

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

Your saliva may be able to tell you if you’ve developed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies, suggests a new medRxiv* preprint study. In immunocompromised groups, salivary Immunoglobulin G (IgG) antibody levels were associated with IgG titers in blood serum 3 to 4 weeks after mRNA vaccination.

5 Oct 2021

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

WHO today published the new edition of its Model Lists of Essential Medicines and Essential Medicines for Children, which include new treatments for various cancers, insulin analogues and new oral medicines for diabetes, new medicines to assist people who want to stop smoking, and new antimicrobials to treat serious bacterial and fungal infections.

1 Oct 2021

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Damaging DNA builds up in the eyes of patients with geographic atrophy, an untreatable, poorly understood form of age-related macular degeneration that causes blindness, new research from the University of Virginia School of Medicine reveals.

1 Oct 2021

Researchers discover how a genetic mutation in mice and monkeys interferes with viruses

A nationwide team of researchers, led by scientists at University of Utah Health and The Rockefeller University, has determined how a genetic mutation found in mice and monkeys interferes with viruses such as HIV and Ebola.

30 Sep 2021

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that Teresa H. Evering, M.D., M.S., a co-lead investigator (with Eric S. Daar, M.D.) for BRII-196/BRII-198 in the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies, will present data for the monoclonal antibody combination at the virtual IDWeek 2021 conference, taking place September 29 – October 3, 2021.

30 Sep 2021

Columbia University and partners launch and operate New York City's first Pandemic Response Institute

Through a groundbreaking new award from New York City Economic Development Corporation (NYCEDC), Columbia University – through its Mailman School of Public Health – and a consortium of academic, community, government, and corporate partners will launch and operate New York City's first Pandemic Response Institute (PRI).

29 Sep 2021

Stigmatization prevents many lessons of HIV pandemic from reaching the society

The HIV pandemic hit the LGBTQI+ community particularly early: people who were already stigmatized.

29 Sep 2021

Study: Life expectancy gaps between Black and white Americans have narrowed by nearly 50% in three decades

Persistent gaps in life expectancy between Black and white Americans have been highlighted by the COVID-19 pandemic. Yet, this gap has narrowed by nearly 50% in three decades, largely due to improvements among Black Americans, according to a study published in the Proceedings of the National Academy of Sciences (PNAS).

29 Sep 2021

New findings highlight the need to expand the toolbox to fight against COVID-19

When Kamlendra Singh flew back to Missouri from India in April, he developed a cough and fever on the plane, despite being vaccinated for COVID-19 and testing negative for the virus right before departure.

28 Sep 2021

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

A University of Michigan lab focused on developing cutting-edge methods to inform effective interventions for drug abuse, HIV and other chronic conditions has been awarded a $13.2 million grant from the National Institute on Drug Abuse.

28 Sep 2021

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

The AIDS Clinical Trials Group (ACTG), the largest global HIV research network, which recently expanded its focus to include evaluating outpatient treatment for COVID-19, today announced that SAB-185, a novel polyclonal antibody therapy, has demonstrated safety and efficacy in phase 2 that meet the criteria for graduation to phase 3 in the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial (ACTG A5401).

28 Sep 2021

COVID Moonshot receives key funding to accelerate drug discovery efforts

The COVID Moonshot, a non-profit, open-science consortium of scientists from around the world dedicated to the discovery of globally affordable and easily-manufactured antiviral drugs against COVID-19 and future viral pandemics has received key funding of £8 million from Wellcome, on behalf of the Covid-19 Therapeutics Accelerator.

28 Sep 2021

Chronic COVID-19 and divergent variants of SARS-CoV-2

A new study discusses the isolation of two variants of concern (VOCs) from an immunocompromised COVID-19 patient.

27 Sep 2021

Hyperbranched polylysine nanopolymer as potential broad-spectrum antiviral against SARS-CoV-2

The findings from this study suggest that HPNs may inhibit viral replication and budding.

27 Sep 2021

HIV News and Research

Research on twins indicates strong genetic influences in COVID-19

Needle exchanges are targeted by eco-rooted lawsuits. A new California law will stop that.

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Binghamton professor collaborates on $3.1 million grant to help Black and Latinx youth living with HIV

AstraZeneca COVID-19 vaccine safe and effective in phase 3 U.S., Chile, and Peru trial

Depressed seroconversion in immunocompromised COVID-19 vaccine recipients

Humoral responses to SARS-CoV-2 are detectable through saliva, scientists find

WHO's new List of Essential Medicines prioritizes access to diabetes and cancer treatments

Damaging DNA builds up in the eyes to drive blinding age-related macular degeneration

Researchers discover how a genetic mutation in mice and monkeys interferes with viruses

ACTG to present data highlighting a new therapeutic for COVID-19 at the virtual IDWeek 2021

Columbia University and partners launch and operate New York City's first Pandemic Response Institute

Stigmatization prevents many lessons of HIV pandemic from reaching the society

Study: Life expectancy gaps between Black and white Americans have narrowed by nearly 50% in three decades

New findings highlight the need to expand the toolbox to fight against COVID-19

U-M lab receives $13.2 million NIDA grant to optimize interventions for substance abuse disorders

Novel polyclonal antibody therapy meets the criteria for graduation to phase 3 in ACTIV-2 trial

COVID Moonshot receives key funding to accelerate drug discovery efforts

Chronic COVID-19 and divergent variants of SARS-CoV-2

Hyperbranched polylysine nanopolymer as potential broad-spectrum antiviral against SARS-CoV-2

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News